Wells Fargo & Company »

Soleno Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6k 115 40.25
2023-09-30 $974 33 29.52
2023-06-30 $172 40 4.30
2022-12-31 $75 38 1.97
2022-09-30 $0 37 0.00